Moderna
MRNA
#1445
Rank
NZ$21.07 B
Marketcap
$54.51
Share price
-3.11%
Change (1 day)
-69.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of December 2024 : NZ$19.09 Billion

According to Moderna 's latest financial reports the company has NZ$19.09 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$NZ$19.32 B-11.77%
2023-12-31$NZ$21.90 B-27.27%
2022-12-31$NZ$30.11 B45.44%
2021-12-31$NZ$20.70 B483.45%
2020-12-31$NZ$3.54 B103.47%
2019-12-31$NZ$1.74 B-23.54%
2018-12-31$NZ$2.28 B159.11%
2017-12-31$NZ$0.88 B-27.56%
2016-12-31$NZ$1.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.13 B-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$81.22 B 325.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$63.76 Million-100.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$77.29 B 304.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$98.22 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$125.22 B 555.81%๐Ÿ‡บ๐Ÿ‡ธ USA